Special Considerations for Rehabilitation

Problem/lnfluence of Medication. The patient was seen by the therapist three mornings each week. After a few sessions, the therapist observed that there were certain days when the patient was able to actively and vigorously participate in the therapy program. On other days, the patient was essentially akinetic, and her active participation in exer- 

The use of levodopa and several other medications has allowed many patients with Parkinson disease to remain active despite the disease s steadily degenerative nature. Levodopa, currently the drug of choice in treating parkinsonism, often produces remarkable 

Ahlskog JE. Parkinson s disease is the initial treatment established Curr Neurol Neurosci Rep. 2003 3 289-295. 

Aminoff MJ. Pharmacologic management of parkinsonism and other movement disorders. In Katzung, BG, ed. Basic and Clinical Pharmacology, 9th ed. New York Lange Medical Books/McGraw Hill 2004. 

Ashkan K, Wallace B, Bell BA, Benabid AL. Deep brain stimulation of the subthalamic nucleus in Parkinson s disease 1993-2003 where are we 10 years on Br J Neurosurg. 2004 18 19-34. 

---